148 related articles for article (PubMed ID: 37814862)
1. [Long non-coding RNA ABHD11-AS1 promotes glycolysis in gastric cancer cells to accelerate tumor progression].
Feng W; Lai Y; Wang J; Xu P
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1485-1492. PubMed ID: 37814862
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.
Lu H; Zhu C; Chen Y; Ruan Y; Fan L; Chen Q; Wei Q
Clin Transl Oncol; 2022 Jun; 24(6):1124-1133. PubMed ID: 35098448
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ABHD11-AS1 boosts gastric cancer development by regulating miR-361-3p/PDPK1 signalling.
Xin H; Yan Z; Cao J
J Biochem; 2020 Nov; 168(5):465-476. PubMed ID: 32678870
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway.
He D; Yue Z; Liu L; Fang X; Chen L; Han H
J Cell Physiol; 2019 Jul; 234(7):12070-12079. PubMed ID: 30537177
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.
Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y
Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2.
Hou S; Zhang X; Yang J
Exp Cell Res; 2022 Jan; 410(1):112929. PubMed ID: 34793775
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis.
Lei X; Li L; Duan X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429229
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
12. Effect of lncRNA BNC2-AS1 on the Proliferation, Migration and Invasion of Gastric Cancer Cells.
Liu C; Yang G; Liu N; Zhou Z; Cao B; Zhou P; Yang B
Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549996
[No Abstract] [Full Text] [Related]
13. EZH2-mediated lncRNA ABHD11-AS1 promoter regulates the progression of ovarian cancer by targeting miR-133a-3p.
Zhang W; Huang X; Shi J
Anticancer Drugs; 2021 Mar; 32(3):269-277. PubMed ID: 33491971
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future.
Zhu D; Hao Q; Qian M; Hu Y; Wu F
J Healthc Eng; 2022; 2022():8387458. PubMed ID: 35186240
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
[TBL] [Abstract][Full Text] [Related]
17. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
Jiang K; Zhi XH; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Xie J; Chen J; Zhu H; Zeidler-Erdely PC; Yang C; Wang Z
Environ Int; 2024 Mar; 185():108494. PubMed ID: 38364571
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MSC-AS1 facilitates the proliferation and glycolysis of gastric cancer cells by regulating PFKFB3 expression.
Jin X; Qiao L; Fan H; Liao C; Zheng J; Wang W; Ma X; Yang M; Sun X; Zhao W
Int J Med Sci; 2021; 18(2):546-554. PubMed ID: 33390824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
